Bruker supports COVID19-NMR Consortium

By The Science Advisory Board staff writers

August 10, 2020 -- Bruker is highlighting its support of a global project called COVID19-NMR that will investigate the structure, dynamics, function, and binding of SARS-CoV-2 viral RNA and proteins using nuclear magnetic resonance (NMR) spectroscopy.

Goethe University in Frankfurt, Germany, initiated the project. It includes a consortium of 30 organizations in 15 countries and will explore the potential of small molecule drugs to bind to the virus's biopolymer structures, Bruker said.

If you like this content, please share it with a colleague!

Related Reading

Bruker releases MALDI-2 to advance mass spectrometry
Bruker announced a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world's first commercial MALDI-2 postionization...

Bruker launches plethora of new products online
Bruker is showcasing a number of its new analytical systems and other products for biopharma and forensics applications. The products include a new gas...

Bruker launches new microscopy technology
On Monday, December 10, at the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO) meeting, Bruker introduced...

Bruker & Murdoch University strategic collaboration announced for phenomics
On Friday, September 20, 2019, Murdoch University (Perth, Australia) and Bruker (Billerica, Massachusetts) announced a strategic collaboration to transform...